-
JANX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Janux Therapeutics (JANX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 431.42 mm | 431.42 mm | 431.42 mm | 431.42 mm | 431.42 mm | 431.42 mm |
Cash burn (monthly) | (no burn) | (no burn) | 9.67 mm | 8.24 mm | 5.58 mm | 3.65 mm |
Cash used (since last report) | n/a | n/a | 20.12 mm | 17.14 mm | 11.60 mm | 7.60 mm |
Cash remaining | n/a | n/a | 411.30 mm | 414.29 mm | 419.82 mm | 423.83 mm |
Runway (months of cash) | n/a | n/a | 42.5 | 50.3 | 75.3 | 116.1 |
13F holders | Current |
---|---|
Total holders | 217 |
Opened positions | 77 |
Closed positions | 23 |
Increased positions | 79 |
Reduced positions | 43 |
13F shares | Current |
---|---|
Total value | 3.27 tn |
Total shares | 71.11 mm |
Total puts | 357.35 k |
Total calls | 687.30 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 10.37 mm | $554.98 bn |
FMR | 8.67 mm | $464.19 bn |
JHG Janus Henderson | 3.56 mm | $190.62 bn |
Paradigm Biocapital Advisors | 3.52 mm | $188.25 bn |
Adage Capital Partners GP, L.L.C. | 3.06 mm | $163.93 bn |
Adage Capital Management | 3.06 mm | $137.14 mm |
Bregua | 3.00 mm | $167.85 mm |
BlackRock | 2.73 mm | $145.94 bn |
Vanguard | 2.14 mm | $114.38 bn |
Cormorant Asset Management | 2.10 mm | $112.43 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 43.6 | 100 | 4.36 k | 82,139 |
3 Feb 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 42.7703 | 816 | 34.90 k | 82,239 |
3 Feb 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 42.0756 | 2,418 | 101.74 k | 83,055 |
3 Feb 25 | Andrew Hollman Meyer | Common Stock | Option exercise | Acquire M | No | No | 4.21 | 3,334 | 14.04 k | 85,473 |
3 Feb 25 | Andrew Hollman Meyer | Stock Option Common Stock | Option exercise | Dispose M | No | No | 4.21 | 3,334 | 14.04 k | 97,333 |
7 Jan 25 | David Alan Campbell | Common Stock | Sell | Dispose S | No | Yes | 60.0008 | 5,000 | 300.00 k | 293,054 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 57.365 | 200 | 11.47 k | 82,139 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 56.7778 | 1,000 | 56.78 k | 82,339 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 55.7587 | 3,444 | 192.03 k | 83,339 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 54.5111 | 5,768 | 314.42 k | 86,783 |